Pilot study of oral tolerance to keyhole limpet hemocyanin in humans: down-regulation of KLH-reactive precursor-cell frequency.
Matsui
M
M
Center for Neurologic Diseases, Harvard Medical School, Boston, Massachusetts 02115, USA.
Hafler
D A
DA
Weiner
H L
HL
D000284:Administration, Oral; D000328:Adult; D000704:Analysis of Variance; D000938:Antigen-Presenting Cells / Q000276:immunology*; D000941:Antigens / Q000008:administration & dosage / Q000276:immunology*; D005260:Female; D006433:Hemocyanins / Q000008:administration & dosage / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular; D018928:Immunity, Mucosal; D007271:Injections, Intradermal; D008297:Male; D008875:Middle Aged; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology; D010865:Pilot Projects; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors
D000941:Antigens; D010047:Ovalbumin; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin